Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,366,000
-25,000 (-1.80%)
Sep 23, 2026, 3:30 PM KST
Samsung Biologics Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, Samsung Biologics stock has a consensus rating of "Strong Buy" and an average price target of ₩1,967,520. The average 1-year stock price forecast is 44.04% higher than the current stock price, while the lowest is ₩1,600,000 (+17.13%) and the highest is ₩2,200,000 (+61.05%).
Price Target: ₩1,967,520 (+44.04%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Samsung Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 14 | 13 | 15 | 14 | 14 |
| Buy | 9 | 10 | 10 | 10 | 10 | 10 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 24 | 23 | 25 | 25 | 25 |
Financial Forecast
Revenue This Year
5.47T
from 4.56T
Increased by 20.00%
Revenue Next Year
6.37T
from 5.47T
Increased by 16.49%
EPS This Year
40.82K
from 26.63K
Increased by 53.31%
EPS Next Year
48.10K
from 40.82K
Increased by 17.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.